BioCentury
ARTICLE | Financial News

Sunesis completes debt financing

April 11, 2016 7:00 AM UTC

Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS), South San Francisco, Calif. Business: Cancer Date completed: 2016-04-01 Type: Debt financing Raised: $15 million Shares outstanding prior: 86.5 million Inve...